{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Astrazeneca Ab", "item": "https://www.patentleaderboard.com/company/astrazeneca-ab"}, {"@type": "ListItem", "position": 3, "name": "Anders Lehmann", "item": "https://www.patentleaderboard.com/inventor/fl:an_ln:lehmann-4"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AL

Anders Lehmann — 7 Patents

Astrazeneca Ab: 6 patents #224 of 1,971Top 15%
ACAstra Co.: 1 patents #218 of 446Top 50%
Mölndal, SE: #102 of 860 inventorsTop 15%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Anders Lehmann has been granted 7 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2000 and the most recent in June 2011. Anders Lehmann ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Anders Lehmann in Mölndal, SE.

Patents per Year

Patents granted per year, 2000 to 2011Bar chart with a peak of 2 patents in 2008.peak 22000: 1 patents20002003: 1 patents20032005: 1 patents20052008: 2 patents20082010: 1 patents20102011: 1 patents2011

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7964609 Use of mGluR5 antagonists for the treatment of gerd Jan Mattsson, Thomas Stormann 2011-06-21 $4,946,000
7807658 Use of GabaB receptor agonists Sverker Von Unge 2010-10-05 $13,377,000
7358245 Treatment of gastroesophageal reflux disease 2008-04-15 $7,679,000
7319095 Use of GABAB receptor agonists Sverker Von Unge 2008-01-15 $31,940,000
6919379 Compounds useful in reflux disease Kevin Fitzpatrick, William B. Geiss, Gunnel E. Sunden, Sverker Von Unge 2005-07-19 $7,941,000
6664069 Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors Paul L. R. Andrews 2003-12-16 $36,744,000
6117908 Use of GABA.sub.B receptor agonists as reflux inhibitors Paul L. R. Andrews 2000-09-12